Cognitive Behavioral Therapy on Adherence and Depression (CBT-AD) Among HIV/AIDS Patients

Last updated: October 28, 2023
Sponsor: Mattu University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Depression

Treatment

Cognitive Behavioral Therapy

Clinical Study ID

NCT06109610
CHS/19/2019
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Depression is highly comorbid with HIV/ AIDS and is associated with worse poor adherence to antiretroviral therapy (ART), and potentially to long-term immune functioning. Cognitive behavioral therapy may solve these problem.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • PLWHA who were 18 years old and above were included in the study

Exclusion

Exclusion Criteria:

  • PLWHA who were previously took CBT and participants with acute physical or mentaldisturbances were excluded.

Study Design

Total Participants: 128
Treatment Group(s): 1
Primary Treatment: Cognitive Behavioral Therapy
Phase:
Study Start date:
May 01, 2021
Estimated Completion Date:
November 01, 2023

Study Description

Depression is highly comorbid with HIV/ AIDS and is associated with worse poor adherence to antiretroviral therapy (ART), and potentially to long-term immune functioning. Poor adherence decreases the benefits of ART as well as chances of prolonged survival. An intervention that integrates CBT for depression with a cognitive behavioral approach to adherence counseling (cognitive behavioral therapy intervention for adherence and depression (CBT-AD)) has been found to be effective in improving adherence and reducing depression in PLWH.

Connect with a study center

  • Mattu University

    Addis Ababa, 318
    Ethiopia

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.